2021
Major Urological Cancer Surgery for Patients is Safe and Surgical Training Should Be Encouraged During the COVID-19 Pandemic: A Multicentre Analysis of 30-day Outcomes
Tan W, Arianayagam R, Khetrapal P, Rowe E, Kearley S, Mahrous A, Pal R, Fowler W, Heer R, Elajnaf M, Douglas-Moore J, Griffiths T, Voss J, Wilby D, Al Kadhi O, Noel J, Vasdev N, McKay A, Ahmad I, Abu-Nayla I, Lamb B, Hill G, Narahari K, Kynaston H, Yousuf A, Kusuma V, Cresswell J, Cooke P, Chakravarti A, Barod R, Bex A, Kelly J, group O. Major Urological Cancer Surgery for Patients is Safe and Surgical Training Should Be Encouraged During the COVID-19 Pandemic: A Multicentre Analysis of 30-day Outcomes. European Urology Open Science 2021, 25: 39-43. PMID: 33458711, PMCID: PMC7796655, DOI: 10.1016/j.euros.2021.01.005.Peer-Reviewed Original ResearchRadical nephrectomyRadical prostatectomyRadical cystectomyPartial nephrectomyHigher American Society of Anesthesiologists (ASA) scoreCounseling patientsGenitourinary (GU) cancersAmerican Society of Anesthesiologists (ASA) scoreAssociated with longer hospital LOSRisk of progressionHigher ASA scoreHospital length of stayUrologic cancer surgeryMinimally invasive approachLonger hospital LOSCase statusLength of stayASA scoreInvasive approachMulticentre analysisCancer operationsUrological cancersCancer surgeryHospital lengthKidney cancer
2018
Intravesical device-assisted therapies for non-muscle-invasive bladder cancer
Tan W, Kelly J. Intravesical device-assisted therapies for non-muscle-invasive bladder cancer. Nature Reviews Urology 2018, 15: 667-685. PMID: 30254383, DOI: 10.1038/s41585-018-0092-z.Peer-Reviewed Original ResearchConceptsNon-muscle-invasive bladder cancerElectromotive drug administrationDevice-assisted therapiesBladder cancerHyperthermic chemotherapyDevice-assisted treatmentsIntravesical adjuvant treatmentHigh-risk diseaseResults of randomized trialsRisk of recurrenceRisk of progressionAlternative to BCGEffective treatment optionSingle-arm study designBladder cancer diagnosisBCG failureRandomized controlled trialsMaintenance regimensAdjuvant treatmentPatient cohortTreatment optionsRandomized trialsDrug AdministrationControlled trialsClinical guidelines